The 7investing Podcast cover image

The 7investing Podcast

Latest episodes

undefined
Mar 10, 2022 • 28min

Important Changes Taking Place in AdTech with Dhaval Kotecha

Businesses around the world spend nearly $800 billion on advertising every year, and two thirds of that is taking place digitally. There are three players who dominate the ads we see when we're glued to the screen, as Alphabet (Nasdaq: GOOGL), Meta Platforms (Nasdaq: FB), and Amazon (Nasdaq: AMZN) together capture 74% of the digital advertising market opportunity. Yet there are big changes underway that might cause a shift in the balance of power. Apple (Nasdaq: AAPL) recently announced in its IOS 14.5 update enhanced privacy controls, which now allow iPhone users to opt-out of seeing personalized advertisements. Specifically, this move shields the mobile device's IDFA identifier from websites and apps, who might want to use it to place targeted advertisements for users. It was a crushing blow for companies who rely on those targeted ads. Facebook/Meta Platforms CFO Dave Wehner has mentioned the move will likely cost their company $10 billion in lost revenue in 2022. As expected, this restricted led to a mass-migration of mobile ad budgets away from Apple iPhones and toward Android devices instead. But now even Google is disrupting its own cash cow in the interest of protecting user privacy. Big G has announced it will be curtailing cross-app ad tracking within the next two years. These are important changes! The business world needs to advertise to drive sales conversions, and it needs direction from the tech giants on how they'll do personalized advertising while still respecting data privacy. Is this the beginning of the the walled gardens of Google and Facebook toppling, and being replaced instead by a new "Open Internet"? Are there new advertising media -- perhaps Connected TV -- that are becoming the battlegrounds that tech companies know they absolutely must win? How should investors decipher these technology changes? And are there specific stock market opportunities they should be considering? To answer these questions, we've brought in an expert. Dhaval Kotecha is an individual investor with years of experience in the digital advertising space. He has worked for programmatic advertising platforms and has accurately read the tea leaves to invest in many of the industry's top-performers. In this exclusive interview, Dhaval chats with 7investing founder Simon Erickson about the higher-level impact of Apple and Google's recent changes. The two discuss Roku's (Nasdaq: ROKU) recent earnings release and what might have caused the stock's significant selloff. Dhaval then describes several programmatic ad platforms, including The Trade Desk (Nasdaq: TTD), PubMatic (Nasdaq: PUBM), and Magnite (Nasdaq: MGNI). And as a fun way to wrap things up, he explains his recent interest in non-fungible token ("NFT") marketplaces and how investors might think about their rising popularity. Publicly-traded companies mentioned in this interview include Alphabet, Amazon, Apple, Magnite, Meta Platforms, PubMatic, ROKU, and The Trade Desk. 7investing's advisors or its guests may have positions in the companies mentioned.
undefined
Mar 8, 2022 • 35min

Should Investors Consider Semler Scientific? A Deep Dive with Adu Subramanian

In this week’s podcast, 7investing lead advisor Luke Hallard catches up with health tech expert investor Adu Subramanian to chat about Semler Scientific (NASDAQ: SMLR) -- an exciting $300M heath care technology business that’s rapidly becoming the standard of care for diagnosing peripheral arterial disease (PAD). PAD is a condition that affects nearly 20 million Americans, yet it’s estimated that only 25% of cases are diagnosed, resulting in costly interventions, and impacting the quality of life for patients.The company received FDA approval for its innovative product, QuantaFlo, in 2015, and today revenues are growing via a unique distribution model of selling directly into insurance companies. In this fun and lively interview, Adu shares his investing thesis for Semler Scientific, breaking down the business model, the incentives for doctors, insurers and patients, and the key financials and investment risks. Adu Subramanian can be found on Twitter @AduSubramanian, or you can read his full investment thesis at his substack, Medtech and Microcaps. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education: https://www.7investing.com Join the 7investing Community Forum: https://discord.gg/6YvazDf9sw Follow us: ► https://www.facebook.com/7investing ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Mar 3, 2022 • 58min

Gamestop, Meme Stocks, and Deep Value Investing with Rod Alzmann

For most of the last ten years, GameStop (NYSE:GME) was nothing more than a legacy retailer in a rapidly changing industry. The once-popular video game merchant experienced lagging sales as gamers shifted to digitally downloading games from buying physical games in stores. Yet as consumer preferences slowly changed, Gamestop's stock was left for dead. Early 2021 is when most of the financial world – me included! – took notice of this story, as Gamestop became the first of the "meme stocks," with Reddit channels and popular social media accounts posting daily memes about hodling and taking down greedy hedge funds. Yet a small group of investors saw a compelling deep value investment opportunity long before the WallStreetBets crowd piled into the trade. Rod Alzmann is one such investor. As highlighted in the new film, GameStop: Rise of the Players, as early as 2017, Alzmann saw that Gamestop's stock price was fundamentally disconnected from its intrinsic value and took a position. Over the next two years, the stock drew down 80%, yet Alzmann kept adding, convinced he was right about its fundamentals. Where the market was pricing in bankruptcy, Alzmann saw a profitable company selling for less than the cash on its balance sheet with a high potential for a short squeeze. In this interview, Alzmann recounts his Gamestop investment, detailing the fundamental case he had for it and dealing with the incredible ups and downs along the way before selling his position into the meme craziness in 2021. Alzmann is now the managing director of Wook Capital, a private investment fund that believes crowdsourcing research from retail investors can offer a pathway to consistent outperformance. During our talk, Alzmann highlighted the influential role of sharing research across social media channels in his Gamestop investment. Finally, near the end of the episode, Alzmann shares his latest value investment: PLBY Group (NASDAQ:PLBY), a legacy media player Wall Street has likewise written off. Alzmann notes that PLBY Group is finding young consumers by licensing its lifestyle brand and focusing on digital initiatives like NFTs. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education: https://www.7investing.com Join the 7investing Community Forum: https://discord.gg/6YvazDf9sw Follow us: ► https://www.facebook.com/7investing ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Mar 1, 2022 • 31min

Things to Know Before Investing in China with James Early

China has mesmerized investors for several decades. Its 1.4 billion population, its intense focus on scientific research, and the rise of its tech-powered sectors like e-commerce, banking, and social media have captured the intrigue and imagination of growth-style investors. The collective market capitalization of all companies listed on the Shanghai Stock Exchange now exceeds $8 trillion, and several Chinese companies are individually worth hundreds of billions. Yet it's possible that Western investors are wearing rose-tinted glasses, and that investing in China isn't in fact that simple. The country's government has very different priorities than Western democracies, its consumers have a very different purchasing behavior, and its tech companies are regulated quite heavily. Americans are perhaps a bit too eager to extrapolate Silicon Valley's success overseas. Finding "the Amazon or China" or "the Facebook of China" isn't quite as easy as it initially may seem. Still, it's undeniable that China is growing quickly and is making a name for itself on the global stage. Are there important things that investors should consider before jumping in? Are there sustainable opportunities that don't involve hidden risks? To help us answer these questions, we've brought in an expert. James Early is the CEO of Stansberry China. He has traveled extensively to the country during the past decade, to help investors better understand China's consumers, its business culture, and its broader investment landscape. In this exclusive interview, James chats candidly with 7investing CEO Simon Erickson about the Middle Kingdom. He explains the higher-level goals that the Chinese Communist Party is trying to achieve and how it thinks about Western capital and investors. He describes the aspirations of the typical Chinese consumer and how the country is attempting to simultaneously balance entrepreneurship and stability. James also points out several risks related to China, such as its tense trade relationships with the United States, its sometimes erratic regulations, and its goal of ultimately annexing Taiwan. He also walks investors through the "variable interest entity" structure that's used by many of its publicly-traded companies and wraps things up by describing how he would recommend approaching China as an investor. Side note from Simon: James and I are former colleagues, who worked together for several years. It was a pleasure to host him for our podcast, and I'm thankful for him sharing his thoughts and opinions. Publicly-traded companies mentioned in this interview include Alibaba, Baidu, Huawei, and Tencent. 7investing's advisors or its guests may have positions in the companies mentioned. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education: https://www.7investing.com Join the 7investing Community Forum: https://discord.gg/6YvazDf9sw Follow us: ► https://www.facebook.com/7investing ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Feb 17, 2022 • 20min

Launching the Space Economy with Rocket Lab CEO Peter Beck and CFO Adam Spice

The commercial space economy is taking off, and it's capturing the imagination of entrepreneurs everywhere. This trillion dollar new horizon is unlocking opportunities that span across the globe and will fundamentally change many industries. But while the potential is certainly there, actually setting up shop in outer space remains very challenging. Companies today need to draw up a business plan, design and build their satellites and infrastructure, launch them into outer space, and then keep everything monitored and operational. Even considered individually, each of those is a monumental task! Yet a company named Rocket Lab (Nasdaq: RKLB) is uniquely rising to this challenge. Self-described as an "end-to-end space company", Rocket Lab looks to simplify the entire process and democratize outer space for business purposes. They design and manufacture custom satellites and rockets, they launch payloads into space, and they manage the infrastructure required for continual support. You can think of them as the one-stop-shop space vendor of preference. And Rocket Lab has even bigger ambitions arising. It initially focused on launching smaller satellites of up to 300 kilograms, yet its newly-unveiled Neutron rocket can carry payloads of up to 8,000 kgs. That means instead of placing individual satellites, it will soon be placing entire satellite constellations. That will give larger customers an opportunity to scale up their commercial operations. The commercial space economy is a higher-altitude movement that absolutely needs to be on your investing radar right now. In an exclusive interview, Rocket Lab's CEO and co-founder Peter Beck and CFO Adam Spice recently spoke with 7investing CEO Simon Erickson and lead advisor Steve Symington. Peter explained why now is the golden era for the space industry and why several customers are asking for dedicated launches as an alternative to ridesharing. Adam described the opportunities that Neutron will enable and the important impact it will have on Rocket Lab as a business. The two also describe upcoming industry consolidation and the opportunity for "Space as a Service". And in the final segment, Peter -- who has been a rocket scientist since his childhood -- describes the things he is most excited about achieving in the coming years. Publicly-traded companies mentioned in this interview include Rocket Lab. 7investing's advisors or its guests may have positions in the companies mentioned.  This episode was originally published on September 7th, 2021.
undefined
Feb 16, 2022 • 22min

The Power of Empowering Others with Nathan Worden

It's been a volatile few months for the stock markets. But long-term investing will endure. The ups and the downs have some investors feeling queasy. Whether it be rising inflation, the Fed considering interest rate hikes, or geopolitical instability, there is no shortage of headlines that might make you believe now is the time to sell everything and head for the hills. But the stock market is also incredibly resilient, and broader-market selloffs can be incredible opportunities to start building long-term positions. When stocks go on sale, it's great to have a watchlist ready. One of our very own 7investing principles is that time is on your side and is the ally of the long-term investor. One of our affiliate partners, Nathan Worden, is similarly interested in empowering others to be long-term investors. He hosts a monthly "Market Game", where contestants pitch ideas to one another with a long-term investing perspective. We've had a lot of fun attending his March Madness inspired presentations before. And we even recently found ourselves competing in one of them! In this episode of our podcast, Nathan chats with 7investing CEO Simon Erickson about his investing style and how he would like to use his Market Game to empower and inspire others. He then runs through four of its most memorable pitches -- including Constellation Brands (NYSE: STZ), Moody's (NYSE: MCO), Vonage (Nasdaq: VG), and Ethereum -- and explains why these might be great long-term investments. Publicly-traded companies and cryptocurrencies mentioned in this podcast include Constellation Brands, Moody's, Vonage, and Ethereum. 7investing's advisors or its guests may have positions in the companies mentioned. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education: https://www.7investing.com Join the 7investing Community Forum: https://discord.gg/6YvazDf9sw Follow us: ► https://www.facebook.com/7investing ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Feb 10, 2022 • 13min

The Future of Raising Capital With DealMaker Co-Founders Rebecca Kacaba and Mat Goldstein

For decades now, investors have gotten used to companies raising money through the traditional IPO. As an opportunity to access the public markets, they would hire underwriters to purchase their shares at a specific price, who would then release and distribute them to the public markets. Yet critics of the traditional IPO have pointed to the all-too-frequent "IPO Pop" phenomenon. Shares would typically get sold to the underwriters at a price below their true market value. And on the first day of trading, the company's market cap would expand to better fit that actual investor potential. It wouldn't be uncommon to see a company's share price double on its first day of trading. We're living in a more efficient world now, where there are new options available for companies to raise money. Direct Listings and Special Purpose Acquisition Companies (SPACs) are alternatives where companies can raise funds without giving away a massive cut to the underwriters. By using digital marketing, they can further appeal directly to their most loyal fans -- and then convert them into part-owners of the business. This is exactly the future that Toronto-based DealMaker envisions. Its cloud-based platform is allowing for companies to raise money as efficiently and transparently as possible. Imagine doing a campaign where you want to raise $1 million for your business. But rather than using Kickstarter or Indiegogo, you can connect directly with your audience and not have to pay them the platform fees. Additionally, you can continually see who's interested -- and get access to more information that could inform the valuation of your future capital raises as well. An example of this was last year's capital raise by the Green Bay Packers. The NFL football team used DealMaker to self-raise $30 million in 48 hours. The Packers are a publicly-owned team and have been for the past 80 years. This was a much more efficient option for them to raise money. In this exclusive interview with 7investing founder Simon Erickson, DealMaker's co-founders Rebecca Kacaba and Mat Goldstein share the pain-points they saw in the financial services industry that led them to create their company. They describe why "self-hosted funding" is becoming an intriguing opportunity, and why establishing a direct connection with investors is important. The two also offer their thoughts about IPOs, Direct Listings, SPACs, blockchains, and NFTs. Publicly-traded companies and teams mentioned in this podcast include The Green Bay Packers. 7investing's advisors or its guests may have positions in the companies mentioned. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education: https://www.7investing.com Join the 7investing Community Forum: https://discord.gg/6YvazDf9sw Follow us: ► https://www.facebook.com/7investing ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Feb 8, 2022 • 25min

The Next Generation of Health Care with Kelly ETFs Founder Kevin Kelly

The disruptive potential of gene editing could have huge implications for health care. Suddenly, several chronic diseases -- which may have required patients to be treated for decades -- have a potential to be fundamentally cured at the genomic level. This is unlocking publicly-tradable investment opportunities. Companies are utilizing the power of CRISPR gene editing, base editing, and prime editing to directly modify patient DNA. Larger pharmaceutical companies are partnering with these smaller drug developers and are building commercial programs that could be worth billions of dollars. Genetic sequencing companies are reducing costs and unlocking broader market adoption, which is rewarding them with greater volumes and higher profits. These opportunities are what has led Kelly ETFs to launch its newest investment product, the CRISPR & Gene Editing Technology ETF (Nasdaq: XDNA). In this exclusive conversation with 7investing CEO Simon Erickson, Kelly ETFs founder Kevin Kelly describes why he brought the ETF to market and how it is less-correlated with other health care funds that are available. He describes his allocation approach and why he isn't afraid to take large stakes in smaller companies. The two also dig into several of the ETF's largest positions, including Beam Therapeutics (Nasdaq: BEAM), Intellia Therapeutics (Nasdaq: NTLA), and Illumina (Nasdaq: ILMN). Publicly-traded companies mentioned in this interview include Abbott Laboratories, Beam Therapeutics, CRISPR Therapeutics, Editas Medicine, Illumina, Intellia Therapeutics, Regeneron, and Thermo Fisher. 7investing's advisors or its guests may have positions in the companies mentioned. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Join the 7investing Community Forum: https://discord.gg/6YvazDf9sw Follow us: ► https://www.facebook.com/7investing ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Feb 3, 2022 • 58min

A Tour of the Financial Industry with John Maxfield

The financial industry is in a familiar place: Legacy banks are being challenged by technologically savvy, disruptive upstarts. Is the banking world about to be turned upside down? Veteran banking analyst and writer John Maxfield doesn't think so. Maxfield is the executive director of the Wilmers Integrity Prize, named after Robert Wilmers, the longtime CEO of MMT Bank. He was formerly the editor-in-chief for Bank Director magazine. Maxfield joined 7investing lead advisor Matthew Cochrane to take a tour of the financial industry, starting with a look at whether neobanks, such as Chime, are a product of VC-backed cheap capital or a legitimate threat to legacy banks. While acknowledging technology is playing a disruptive role in the banking industry overall, Maxfield believes big banks especially have the firepower to keep pace in the rapidly changing industry while wondering if the smaller upstarts can even achieve profitability. Next, Maxfield and Cochrane explore the recent explosion in M&A activity in the banking space. In 2019, SunTrust came together with BB&T in a merger of equals, creating Truist Financial Corp (NYSE:TFC), the 6th largest bank in the U.S. by assets. This was followed last June by PNC Financial Services Group (NYSE:PNC) completing its $11.5B acquisition of BBVA USA, making it one of the largest U.S. commercial banks. Banking consolidation is a phenomenon that Maxfield traces back to the early 1980s when Congress allowed banks to acquire financial institutions in other states. While Maxfield believes this trend will stay intact, he questions whether the majority of such deals create value for shareholders. Of course, no discussion about the banking space is complete without a tour of the big four banks dominating the domestic landscape: Bank of America (NYSE:BAC), Citigroup (NYSE:C), JPMorgan Chase (NYSE:JPM), and Wells Fargo (NYSE:WFC). Finally, Maxfield explains why Triumph Bancorp (NASDAQ:TBK) is a hidden gem, an under-the-radar community bank based in Dallas, TX, attempting an ambitious project in a big industry! Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Join the 7investing Community Forum: https://discord.gg/6YvazDf9sw Follow us: ► https://www.facebook.com/7investing ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Feb 1, 2022 • 24min

7 Deadly Sins During a Market Selloff

Do you find your emotions dictating your investment decisions, or use margin trading or derivatives to try to magnify your investment returns? In difficult market conditions with growth stocks facing significant drawdowns almost daily, are you tempted to chase your losers, hoping to get even? If so, you may be falling prey to one or more of the ‘seven deadly sins during a market selloff’! In this episode of the 7investing podcast, Lead Advisors Anirban Mahanti and Luke Hallard discuss seven products and habits that can cause tremendous damage to an investor’s long-term returns. Not only will these behaviours likely cause you to lose sleep at night, but they can also have a big impact on your portfolio. Publicly-traded companies mentioned in this podcast include GameStop, Apple, Netflix and Tesla. 7investing Lead Advisors Anirban Mahanti and Luke Hallard may own shares in the companies mentioned in the podcast. Timestamps 00:00 - Introduction 01:35 - Using Margin 03:50 - Shorting Stocks 06:57 - Short-Term Options 11:48 - Emotional Trading/FOMO 13:31 - Growth Investors Chasing Defensive Stocks 16:28 - Selling Positions to Start or Add to Positions 18:25 - Chasing Your Losers Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Join the 7investing Community Forum: https://discord.gg/6YvazDf9sw Follow us: ► https://www.facebook.com/7investing ► https://twitter.com/7investing ► https://instagram.com/7investing

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode